Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy

Sleep

Volumn 31, Issue 8, 2008, Pages 1119-1126

  Mishima, Kazuo ^a,b   Fujiki, Nobuhiro ^a   Yoshida, Yasushi ^a   Sakurai, Takeshi ^c   Honda, Makoto ^a   Mignot, Emmanuel ^a   Nishino, Seiji ^a  

^a STANFORD UNIVERSITY   (United States)

^b National Center of Neurology and Psychiatry   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cataplexy; Dog; Human; Hypocretin orexin; Hypocretin orexin receptors; Mice; Narcolepsy; RT PCR

Indexed keywords

OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATAPLEXY; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONAVIRUS; FEMALE; FRONTAL CORTEX; GENE THERAPY; GENETIC ANALYSIS; HUMAN; MALE; MOUSE; NARCOLEPSY; NONHUMAN; PONS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOGS; FEMALE; FRONTAL LOBE; GENE EXPRESSION; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MIDDLE AGED; NARCOLEPSY; NEUROPEPTIDES; PONS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIES SPECIFICITY;

EID: 48949095544     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nishino S, Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 1997;52:27-78.
2. Bassetti C, Aldrich M. Narcolepsy. Neurol Clin 1996;14:545-71.
3. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-76.
4. Ripley B, Fujiki N, Okura M, Mignot E, Nishino S. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol Dis 2001;8:525-34.
5. Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001;30:345-54.
6. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-51.
7. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
8. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
9. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
10. Crocker A, Espana RA, Papadopoulou M, et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 2005;65:1184-8.
11. Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology 2005;65:1189-92.
12. Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 2004;101:4649-54.
13. Thannickal TC, Siegel JM, Nienhuis R, Moore RY. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 2003;13:340-51.
14. Fujiki N, Ripley B, Yoshida Y, Mignot E, Nishino S. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin ligand deficient narcoleptic dog. Sleep 2003;6:953-9.
15. Terao A, Peyron C, Ding J et al. Prepro-hypocretin (prepro-orexin) expression is unaffected by short- term sleep deprivation in rats and mice. Sleep 2000;23:867-74.
16. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed.: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
17. Marcus JN, Aschkenasi CJ, Lee CE, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001;435:6-25.
18. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
19. Shiba T, Ozu M, Yoshida Y, Mignot E, Nishino S. Hypocretin stimulates [(35)S]GTP gamma S binding in Hcrtr 2-transfected cell lines and in brain homogenate. Biochem Biophys Res Commun 2002;294:615-20.
20. Willie JT, Chemelli RM, Sinton CM et al. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 2003; 38: 715-30.